三孚股份(603938.SH):擬設立三孚(天津)化工科技
格隆匯1月12日丨三孚股份(603938.SH)公佈,2022年1月12日,公司第四屆董事會第十五次會議審議並通過了《關於投資設立全資子公司的議案》,根據公司的經營計劃和發展需求,公司擬以自有資金設立三孚(天津)化工科技有限公司(最終名稱以當地主管機構註冊登記為準)。
根據公司的經營計劃和發展需求,成立全資子公司三孚(天津)化工科技有限公司有利於公司吸納高素質研發、生產及國際貿易等方面人才,從而提升公司生產、研發能力,為公司持續發展注入活力,符合公司整體的發展規劃,不會對公司財務和經營狀況產生不利影響,不會損害公司及股東特別是中小股東的權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.